See also this year's filing and all EDGAR filings for this company.
PDF Report 0001694665_2020_Evelo_Biosciences_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001694665')"} |
Graph
Absolute values for 0001694665, Evelo Biosciences Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 81,009,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 8,341,000 |
| 3 | remainder_Assets | 1,570,000 |
| 4 | LiabilitiesCurrent | 9,743,000 |
| 5 | LiabilitiesNoncurrent | 19,832,000 |
| 6 | remainder_Liabilities | 1,148,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 23,229,000 |
| 9 | ResearchAndDevelopmentExpense | 63,128,000 |
| 10 | remainder_Expenses | 190,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,075,000 |
| 13 | remainder_ComprehensiveNetIncome | 18,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 90,920,000 |
| 1 | Liabilities | 30,723,000 |
| 2 | Expenses | 86,547,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 60,197,000 |
| 5 | NetIncome | -85,472,000 |
| 6 | ComprehensiveNetIncome | -85,463,000 |
| 7 | BaseVar | 104,641,500 |
| 8 | EconomicCapitalRatio | 0.297 |
Edgar->Model Mapping
Feature Distribution
Change over Time
